A Live-Attenuated Equine Influenza Vaccine Stimulates Innate Immunity in Equine Respiratory Epithelial Cell Cultures That Could Provide Protection From Equine Herpesvirus 1

被引:3
作者
Zarski, Lila M. [1 ]
Vaala, Wendy E. [2 ]
Barnett, D. Craig [2 ]
Bain, Fairfield T. [2 ]
Soboll Hussey, Gisela [1 ]
机构
[1] Vet Med Ctr, Coll Vet Med, Dept Pathobiol & Diagnost Invest, E Lansing, MI USA
[2] Merck & Co Inc, Kenilworth, NJ USA
关键词
horse; EHV-1; equine influenza vaccine; epithelial cell; mucosal immunity; A VIRUS-INFECTION; ANTIBODY-RESPONSES; MONONUCLEAR-CELLS; DOWN-REGULATION; HUNTER VALLEY; TYPE-1; EHV-1; INTERFERON; PONIES; EXPRESSION;
D O I
10.3389/fvets.2021.674850
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Equine herpesvirus 1 (EHV-1) ubiquitously infects horses worldwide and causes respiratory disease, abortion, and equine herpesvirus myeloencephalopathy. Protection against EHV-1 disease is elusive due to establishment of latency and immune-modulatory features of the virus. These include the modulation of interferons, cytokines, chemokines, antigen presentation, and cellular immunity. Because the modulation of immunity likely occurs at the site of first infection-the respiratory epithelium, we hypothesized that the mucosal influenza vaccine Flu Avert(R) I.N. (Flu Avert), which is known to stimulate strong antiviral responses, will enhance antiviral innate immunity, and that these responses would also provide protection from EHV-1 infection. To test our hypothesis, primary equine respiratory epithelial cells (ERECs) were treated with Flu Avert, and innate immunity was evaluated for 10 days following treatment. The timing of Flu Avert treatment was also evaluated for optimal effectiveness to reduce EHV-1 replication by modulating early immune responses to EHV-1. The induction of interferons, cytokine and chemokine mRNA expression, and protein secretion was evaluated by high-throughput qPCR and multiplex protein analysis. Intracellular and extracellular EHV-1 titers were determined by qPCR. Flu Avert treatment resulted in the modulation of IL-8, CCL2, and CXCL9 starting at days 5 and 6 post-treatment. Coinciding with the timing of optimal chemokine induction, our data also suggested the same timing for reduction of EHV-1 replication. In combination, our results suggest that Flu Avert may be effective at counteracting some of the immune-modulatory properties of EHV-1 at the airway epithelium and the peak for this response occurs 5-8 days post-Flu Avert treatment. Future in vivo studies are needed to investigate Flu Avert as a prophylactic in situations where EHV-1 exposure may occur.
引用
收藏
页数:16
相关论文
共 70 条
  • [1] Prevalence of latent, neuropathogenic equine herpesvirus-1 in the Thoroughbred broodmare population of central Kentucky
    Allen, G. P.
    Bolin, D. C.
    Bryant, U.
    Carter, C. N.
    Giles, R. C.
    Harrison, L. R.
    Hong, C. B.
    Jackson, C. B.
    Poonacha, K.
    Wharton, R.
    Williams, N. M.
    [J]. EQUINE VETERINARY JOURNAL, 2008, 40 (02) : 105 - 110
  • [2] Antemortern detection of latent infection with neuropathogenic strains of equine herpesvirus-1 in horses
    Allen, George P.
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2006, 67 (08) : 1401 - 1405
  • [3] Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses
    Allen, George P.
    [J]. AMERICAN JOURNAL OF VETERINARY RESEARCH, 2008, 69 (12) : 1595 - 1600
  • [4] Peptide transport activity of the transporter associated with antigen processing (TAP) is inhibited by an early protein of equine herpesvirus-1
    Ambagala, APN
    Gopinath, RS
    Srikumaran, S
    [J]. JOURNAL OF GENERAL VIROLOGY, 2004, 85 : 349 - 353
  • [5] Needle-free influenza vaccination
    Amorij, Jean-Pierre
    Hinrichs, Wouter L. J.
    Frijlink, Henderik W.
    Wilschut, Jan C.
    Huckriede, Anke
    [J]. LANCET INFECTIOUS DISEASES, 2010, 10 (10) : 699 - 711
  • [6] Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in Adults
    Barria, Maria Ines
    Garrido, Jose Luis
    Stein, Cheryl
    Scher, Erica
    Ge, Yongchao
    Engel, Stephanie M.
    Kraus, Thomas A.
    Banach, David
    Moran, Thomas M.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (01) : 115 - 124
  • [7] What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?
    Belyakov, Igor M.
    Ahlers, Jeffrey D.
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 183 (11) : 6883 - 6892
  • [8] Glycoprotein G isoforms from some alpha herpesviruses function as broad-spectrum chemokine binding proteins
    Bryant, NA
    Davis-Poynter, N
    Vanderplasschen, A
    Alcami, A
    [J]. EMBO JOURNAL, 2003, 22 (04) : 833 - 846
  • [9] A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge
    Chambers, TM
    Holland, RE
    Tudor, LR
    Townsend, HGG
    Cook, A
    Bogdan, J
    Lunn, DP
    Hussey, S
    Whitaker-Dowling, P
    Youngner, JS
    Sebring, RW
    Penner, SJ
    Stiegler, GL
    [J]. EQUINE VETERINARY JOURNAL, 2001, 33 (07) : 630 - 636
  • [10] Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures
    Fischer, William A., II
    Chason, Kelly D.
    Brighton, Missy
    Jaspers, Ilona
    [J]. VACCINE, 2014, 32 (15) : 1761 - 1767